Scientific Publications
Peer reviewed articles including original research, reviews, systematic reviews, and other publications related to our technological PharmaFlow platform, partner collaborations and research developments where Vivia Biotech technology displays an essential role

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

EJHaem
2023

Improving NK Cell Function in Multiple Myeloma with NKTR-225, a Novel Polymer-Conjugated Human IL-15

Blood Adv
2022

Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy

Frontiers in Oncology
2022

Biomarker driven phase Ib clinical trial of OPB 111077 in acute myeloid leukemia

Medicine International
2022

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

Blood
2021

Ex-vivo drug testing predicts chemosensitivity in acute myeloid leukemia

J Leukoc Biol
2020

Improving the prediction of AML outcomes by complementing mutational profiling with ex vivo chemosensitivity

British Journal of Haematology
2020

Differences in ex-vivo chemosensitivity to anthracyclines in first line acute myeloid leukemia

Mediterranean Journal of Hematology and Infectious Diseases
2019

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

Leukemia Research
2019

The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML

Oncogene
2018

CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

Clin Cancer Res
2018

Ruxolitinib in combination with prednisone and nilotinib exhibit a synergistic effect in myelofibrosis

Haematologica
2018

Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma

Cell Reports
2018

Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review

Annals of Hematology
2018

A Novel Ex Vivo Assay Reveals Antiproliferative Effects of Idelalisib and Ibrutinib on CLL Cells

Oncotarget
2018

A Positive Allosteric Modulator of the Serotonin 5 HT2C Receptor for Obesity

Journal of Medicinal Chemistry
2017

Preclinical anti-myeloma activity of EDOS101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

Journal of Hematology & Oncology
2017

Drug Discovery Testing Compounds in Patients Samples by Automated Flow Cytometry

SLAS Technology
2017

Functional role and therapeutic targeting of p21-associated kinase 4 (PAK4) in multiple myeloma

Blood
2017

Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia

PLoS ONE
2017

Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia

The Journal of Pharmacology and Experimental Therapuetics
2015

Pharmacological Profiles of Acute Myeloid Leukemia treatments in patient samples by automated flow cytometry; a bridge to individualized medicine

Clinical Lymphoma, Myeloma and Leukemia
2014

more about resources

Click Here